Literature DB >> 10799321

The N-terminal domains of cyclin-dependent kinase inhibitory proteins block the phosphorylation of cdk2/Cyclin E by the CDK-activating kinase.

K B Rank1, D B Evans, S K Sharma.   

Abstract

It has been suggested that binding of p27 and p21 kinase inhibitory proteins (KIPs) to cyclin-dependent kinases (cdks) render them inaccessible to cdk-activating kinase (CAK), presumably by steric hindrance by the C-terminal residues. However, this common mechanism of inhibition is inconsistent with the known structural divergence in the p27 and p21 C-terminal domains. Therefore, we studied the direct binding of N-terminal minimal domain of p27 (amino acids 28-81) to cdk2/cyclin E. An unlabeled p27 minimal domain, mutated in the N-terminal LFG motif, was unable to compete with a labeled minimal domain for binding to cdk2/cyclin E. The p27 and its minimal domain inhibited CAK-mediated phosphorylation of cdk2/cyclin E. This inhibitory effect was significantly diminished with p27 minimal domain mutated in the LFG motif. A synthetic peptide, ACRRLFGPVDSE, from the N-terminal residues 17-28 of p21, was also a potent inhibitor of CAK-mediated cdk2/cyclin E phosphorylation. Taken together, these results show that anchoring of p27 or p21 KIPs to cyclin E via the N-terminal LFG-containing motif can block CAK access to its cdk2/cyclin E substrate. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799321     DOI: 10.1006/bbrc.2000.2648

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Chemo-Genetic Interactions Between Histone Modification and the Antiproliferation Drug AICAR Are Conserved in Yeast and Humans.

Authors:  Delphine Albrecht; Johanna Ceschin; Jim Dompierre; Florian Gueniot; Benoît Pinson; Bertrand Daignan-Fornier
Journal:  Genetics       Date:  2016-10-05       Impact factor: 4.562

2.  Ribociclib Inhibits P-gp-Mediated Multidrug Resistance in Human Epidermoid Carcinoma Cells.

Authors:  Lei Zhang; Biwei Ye; Yunfeng Lin; Yi-Dong Li; Jing-Quan Wang; Zhuo Chen; Feng-Feng Ping; Zhe-Sheng Chen
Journal:  Front Pharmacol       Date:  2022-04-01       Impact factor: 5.988

3.  Cyclin E and SV40 small T antigen cooperate to bypass quiescence and contribute to transformation by activating CDK2 in human fibroblasts.

Authors:  Elena Sotillo; Judit Garriga; Alison Kurimchak; Xavier Graña
Journal:  J Biol Chem       Date:  2008-02-14       Impact factor: 5.157

4.  The Sp1 family of transcription factors is involved in p27(Kip1)-mediated activation of myelin basic protein gene expression.

Authors:  Qiou Wei; W Keith Miskimins; Robin Miskimins
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

5.  Genome-wide changes accompanying knockdown of fatty acid synthase in breast cancer.

Authors:  Lynn M Knowles; Jeffrey W Smith
Journal:  BMC Genomics       Date:  2007-06-12       Impact factor: 3.969

Review 6.  Regulation of Cell Cycle Progression by Growth Factor-Induced Cell Signaling.

Authors:  Zhixiang Wang
Journal:  Cells       Date:  2021-11-26       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.